Nottingham-based business incubator BioCity has received a fresh round of development capital from Blue Skies Investments (BSI) and BGF.
Founded in 2002, BioCity is the UK’s largest life science incubation business, providing specialist workspace for growing life science companies, including access to high-end equipment, shared services and training, as well as business advice through its expert network.
BioCity will use the funding to expand its activity, allowing it to develop even more promising young life science companies in the UK.
BioCity works with businesses from all areas of the life science industry, including cutting-edge therapeutics, medical devices, diagnostics, contract research, digital health and industrial and environmental biotechnology.
Dr Glenn Crocker MBE, Chairman of BioCity, comments: “We’re delighted to welcome BGF as a partner to the BioCity group alongside BSI as we continue to expand our offering to the UK’s life science community.
“BGF’s ability to provide long-term capital and support, with the potential for additional investment, made them the right choice for us.
“BSI also has a wealth of experience in the life sciences sector and we’re also looking forward to drawing on both organizations investment expertise for our own plans to bring promising life science businesses the funds they need to develop.”